BCL2L1 and acute lymphoblastic leukemia: Upon withdrawal of venetoclax for two weeks, expression of both BCL2 and BCL2L1 was decreased in MOLT-16 and ALL-SIL cells, while BCL2 expression was increased in LOUCY cells (Figure 3D and Supplementary Figure S3).